Create a free account to find warm leads

With Highperformr, you can:

Discover ready-to-buy prospects using real-time intent signals
Find companies and people that match your ideal customer profile
Enrich your data with verified emails, social profiles, and more
and much more...

Already have account?

Thomas Clozel Email & Phone Number

Chief Executive Officer and Co-founder, OWKIN

New York

United States

View Thomas Clozel’s Email & Phone Number for FREE

100 FREE credits to access up to 50 email addresses

Thomas's contact information

Thomas’s email address

XXXX@XX.XX

Email address

Thomas’s phone numbers

Phone number

Unlock contact information

Buyer intent signals for Thomas

A “Signal” in Highperformr AI delivers actionable insights to help your sales, marketing and GTM team prioritize and engage the right prospects. Uncover opportunities, and make smarter decisions.

Decision Maker

ICP Match

Recent Promotion

Leadership

Prouilding

Corpnance

Cte Finance

Corporate Finance

*Example signal, not calculated in real time

See signals

Thomas’s work information

OWKIN

Chief Executive Officer and Co-founder

8 years 6 months

Jun 2016

now

Fragment (YC S23)

Seed Investor

Nov 2023

Dec 2023

Thomas’s education information

Thomas’s skills

Leadership

Product building

Corporate Finance

FAQ about Thomas

What is Thomas email address?

Email Thomas Clozel at XXXX@XXX.XX. This email is the most updated Thomas Clozel's email found in 2024.

Unlock contact information

What is Thomas's phone number?

Thomas's phone number is .

Unlock contact information

Summary

Thomas Clozel, based in New York, New York, United States, is the Chief Executive Officer and Co-founder at OWKIN. He has held various positions including Brain Trust at XPRIZE, Member of the Board at Université Paris-Saclay, Non-operational Co-founder at Cure51, Advisor at EQT Group, Non-operational Co-founder at Bioptimus, Venture Advisor at Sofinnova Partners, and Advisor at GRACE. Previously, he was a Seed Investor at Fragment and Osium AI.